STUDY SEARCH RESULTS

1 study found for your search request:  1654-007

Clesrovimab (MK-1654) in Infants and Children at Increased Risk for Severe Respiratory Syncytial Vir...
Condition: RSV infection
Minimum Age: N/A, Maximum Age: 1 years
Gender: All
Study ID: NCT04938830
Status: Recruiting
Has Enrolling Locations in US or Canada




Copyright © 2024 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  U.S. Corporate Site